| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/23/2011 | US20110152249 Evaluating central nervous system |
| 06/23/2011 | US20110152248 Bridgehead amine ring-fused indoles and indolines |
| 06/23/2011 | US20110152247 Benzoxazepine compounds, their preparation and use |
| 06/23/2011 | US20110152246 Novel inhibitors of hepatitis c virus replication |
| 06/23/2011 | US20110152245 Substituted benzamides |
| 06/23/2011 | US20110152244 Pyrrolopyrimidine compounds and their uses |
| 06/23/2011 | US20110152243 Novel thienopyrrole compounds |
| 06/23/2011 | US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists |
| 06/23/2011 | US20110152241 Novel compounds as receptor modulators with therapeutic utility |
| 06/23/2011 | US20110152240 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors |
| 06/23/2011 | US20110152239 10a-azalide compound having 4-membered ring structure |
| 06/23/2011 | US20110152238 Pharmaceutical compounds |
| 06/23/2011 | US20110152237 Chemical Compounds |
| 06/23/2011 | US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 06/23/2011 | US20110152235 Aminopyrimidine Kinase Inhibitors |
| 06/23/2011 | US20110152234 Novel Compounds |
| 06/23/2011 | US20110152233 Pyrrolidine compounds |
| 06/23/2011 | US20110152232 Sulfonamide compounds and uses thereof |
| 06/23/2011 | US20110152231 Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms |
| 06/23/2011 | US20110152230 Photoactive Metal Nitrosyls For Blood Pressure Regulation And Cancer Therapy |
| 06/23/2011 | US20110152229 Betulinic acid derivatives as anti-hiv agents |
| 06/23/2011 | US20110152228 Sprayable pharmaceutical compositions comprising a corticoid and an oily phase |
| 06/23/2011 | US20110152227 Deuterium labelled derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof |
| 06/23/2011 | US20110152226 Development of New Selective Estrogen Receptor Modulators |
| 06/23/2011 | US20110152225 PPAR-Gamma Agonists for the Induction of Cationic Antimicrobial Peptide Expression as Immunoprotective Stimulants |
| 06/23/2011 | US20110152224 Myeloperoxidase, a risk indicator for cardiovascular disease |
| 06/23/2011 | US20110152223 Therapeutic agent for anca-related vasculitis |
| 06/23/2011 | US20110152222 Use of 2,5-dihydroxybenzene derivatives for the treatment of arthritis and pain |
| 06/23/2011 | US20110152221 PAK1 Agonists and Methods of Use |
| 06/23/2011 | US20110152220 Methods of diagnosing, preventing and treating bone mass diseases |
| 06/23/2011 | US20110152219 Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders |
| 06/23/2011 | US20110152218 Crystalline phospholipid, method for its production and use in treating damaged tissue |
| 06/23/2011 | US20110152217 Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2]oxaborol-1-ol |
| 06/23/2011 | US20110152216 Anaesthetic composition |
| 06/23/2011 | US20110152215 Riboswitches, methods for their use, and compositions for use with riboswitches |
| 06/23/2011 | US20110152214 Silk polymer-based adenosine release: therapeutic potential for epilepsy |
| 06/23/2011 | US20110152213 Riboswitches, methods for their use, and compositions for use with riboswitches |
| 06/23/2011 | US20110152212 Aqueous Formulations |
| 06/23/2011 | US20110152211 Methods and formulations for reducing amphotericin b treatment side effects |
| 06/23/2011 | US20110152210 Polyphenol compounds for inhibiting proteasome and uses thereof |
| 06/23/2011 | US20110152209 Core 2 GlcNAc-T Inhibitors |
| 06/23/2011 | US20110152208 Use of Compounds Extracted from Momordica Charantia L. in the Manufacture of Medicaments for Prevention and Treatment of Diabetes and Obesity |
| 06/23/2011 | US20110152207 Use of vitamin d glycosides and sulfates for treatment of disease |
| 06/23/2011 | US20110152206 Therapeutic combinations for use in neoplasia |
| 06/23/2011 | US20110152205 Application of puerarin in the preparation of p2x3 mediated drugs for pain/nervous system diseases |
| 06/23/2011 | US20110152204 Treatment of Obesity or Diabetes with Bile Acid Sequestrants |
| 06/23/2011 | US20110152201 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 06/23/2011 | US20110152175 Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof |
| 06/23/2011 | US20110152172 Methods of Treating Pulmonary Diseases and Disorders by Modulating Calcium/Calmodulin Dependent Protein Kinase II Activity |
| 06/23/2011 | US20110152169 Sparc anti-inflammatory activity and uses thereof |
| 06/23/2011 | US20110152168 Antiadhesive carbohydrates |
| 06/23/2011 | US20110152083 Network copolymer crosslinked compositions and products comprising the same |
| 06/23/2011 | US20110151558 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
| 06/23/2011 | US20110151035 Smoking Cessation Lozenge Containing Tobacco Alkaloid And Silver Salt |
| 06/23/2011 | US20110151033 Orthosiphon stamineus extracts for use as a cognition enhancer |
| 06/23/2011 | US20110151029 Paxillin Stimulating Compositions and Cosmetic Uses Thereof |
| 06/23/2011 | US20110151028 Topical vaginal preparation |
| 06/23/2011 | US20110151025 Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary Infections |
| 06/23/2011 | US20110151024 Compositions and Methods for Preventing Migraines |
| 06/23/2011 | US20110151023 Combination therapy with parp inhibitors |
| 06/23/2011 | US20110151022 Thiotungstate analogues and uses thereof |
| 06/23/2011 | US20110151020 Active substance combination with gemcitabine for the treatment of epithelial cancer |
| 06/23/2011 | US20110151014 Microcrystalline cellulose and calcium carbonate compositions useful as recompactible pharmaceutical excipients |
| 06/23/2011 | US20110151013 Amphiphilic block copolymers for nucleic acid delivery |
| 06/23/2011 | US20110151012 Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents |
| 06/23/2011 | US20110151009 Use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy |
| 06/23/2011 | US20110151008 Pulmonary Delivery for Levodopa |
| 06/23/2011 | US20110151003 Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
| 06/23/2011 | US20110151002 Sustained release pharmaceutical compositions comprising quetiapine |
| 06/23/2011 | US20110151001 Pharmaceutical composition for external application containing prochlorperazine |
| 06/23/2011 | US20110150997 Elvucitabine pharmaceutical compositions |
| 06/23/2011 | US20110150996 Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino] -2-pyrimidinyl]amino]benzonitrile |
| 06/23/2011 | US20110150994 Modified Release Formulation |
| 06/23/2011 | US20110150992 Quinine formulations, method of making, and method of use thereof |
| 06/23/2011 | US20110150991 Abuse resistant drugs, method of use and method of making |
| 06/23/2011 | US20110150990 Abuse resistant drugs, method of use and method of making |
| 06/23/2011 | US20110150989 Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans |
| 06/23/2011 | US20110150988 Dietary supplement composition for blood lipid health |
| 06/23/2011 | US20110150986 Quinine formulations, method of making, and metho of use thereof |
| 06/23/2011 | US20110150984 Methods of increasing the bioavailability and/or cellular update of drugs |
| 06/23/2011 | US20110150981 Compounds for Use in Therapy |
| 06/23/2011 | US20110150979 Methods for diagnosis, prognosis and treatment of primary and metastatic basal-like breast cancer and other cancer types |
| 06/23/2011 | US20110150977 Antimicrobial polymers and methods of manufacture thereof |
| 06/23/2011 | US20110150976 Transdermal delivery of oligosaccharides |
| 06/23/2011 | US20110150974 Agent For Oral Mucosal Administration |
| 06/23/2011 | US20110150971 Abuse resistant drugs, method of use and method of making |
| 06/23/2011 | US20110150970 Abuse resistant drugs, method of use and method of making |
| 06/23/2011 | US20110150969 Abuse resistant drugs, method of use and method of making |
| 06/23/2011 | US20110150968 Dissolvable dietary supplement strip and methods for using the same |
| 06/23/2011 | US20110150967 Method of reducing incidence of intraocular pressure associated with intraocular use of corticosteroids |
| 06/23/2011 | US20110150966 Degradable polymers incorporating gamma-butyrolactone |
| 06/23/2011 | US20110150964 Aptamer-coated implant, process of production, and uses |
| 06/23/2011 | US20110150955 Products and Methods for Reducing Malodor from the Pudendum |
| 06/23/2011 | US20110150946 Transdermal Delivery of Apomorphine Using Microneedles |
| 06/23/2011 | US20110150945 Oral pharmaceutical formulation for omeprazole comprising a specific separation layer |
| 06/23/2011 | US20110150944 Structured triglycerides and emulsions comprising same |
| 06/23/2011 | US20110150943 Adhesive for medical applications and means for haemostasis |
| 06/23/2011 | US20110150942 Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives |
| 06/23/2011 | US20110150941 Epithelial delivery |
| 06/23/2011 | US20110150938 Supercrystalline Colloidal Particles and Method of Production |